|
|
Christopher Etheridge PhD
MCPP MRSC, BSc (Hons) Phyto, BSc (Hons) Chem,
CChem, DoIC, ARCS Medical Herbalist |
|
Chris
Etheridge’s qualifications, experience and publications
Chris
Etheridge is a leading Medical Herbalist (Phytotherapist) with extensive
experience as a herbal practitioner, researcher and
writer. He is also one of Britain’s
foremost Integrated Cancer Specialists with his own dedicated cancer
consultancy, drchrisetheridge.co.uk or integratedcancerhealthcare.co.uk.
Chris is an active member of the College of Practitioners
of Phytotherapy (CPP), a major professional governing body that sets the
highest standards of practice in herbal medicine. He is a guest lecturer at the
Centre for Nutrition Education (cnelm.co.uk), the Institute of Optimum Nutrition (ION) (ion.ac.uk), the Northern College of Acupuncture (chinese-medicine.co.uk) and The Haven (thehaven.org.uk). Chris is a writer for the charity Action for ME’s magazine (afme.org.uk), and scientific advisor for Advanced
Orthomolecular Research (aoreurope.co.uk) and the charities Yes to Life (yestolife.org.uk) and
Kids Integrated Cancer Treatments (kict.info).
In the past, he has worked closely with Dr Rosy Daniel (formerly of the Bristol
Cancer Centre and now the Penny Brohn Centre) to create an integrated workbook
for recently diagnosed cancer patients.
Chris holds a first class honours BSc and a PhD in Medicinal
Chemistry from Imperial College, London. He was a Lecturer and Research Fellow in Gene Therapy in Imperial’s
Department of Chemistry and in the Department of
Biochemistry and Molecular Genetics at St
Mary’s Hospital, where he also received further training, from 1995-99. His research into gene therapy
for cancer, cystic fibrosis, rheumatoid arthritis and Parkinson’s disease
produced numerous publications (listed below)
and three commercial medical patents, which resulted in a £3.5 million
investment from Mitsubishi for the construction of a new Genetic Therapies
Centre at Imperial College. Chris also co-founded a genetic therapy company,
IC-Vec, through Imperial Innovations Ltd, in order to manufacture and supply
his patented drugs for clinical use, and to carry out further gene therapy
research to develop improved treatments for cystic fibrosis and rheumatoid
arthritis. IC-Vec was subsequently purchased by the Mitsubishi Chemical
Company.
Chris believes passionately in the medicinal use of
herbs as safer, effective alternatives and adjuncts to orthodox medicines, and
he is fully committed to a holistic “whole person” approach to treating his
patients. These values led him to complete his professional training on the four-year
Herbal Medicine degree programme at the College of Phytotherapy, East Sussex.
He graduated in 2006 with a first class honours BSc and published his National
Institute of Medical Herbalists (NIMH) award-winning dissertation on quality control in herbal medicine
in the Journal of Pharmacy and Pharmaceutical Sciences. (You can read the article here.)
Professional
membership
Chris is a Council
Member for the College of Practitioners of Phytotherapy (CPP).
The College of Practitioners of Phytotherapy (CPP)
is a professional membership organisation established in 1991 to
ensure the highest standards of excellence in herbal medicine
(phytotherapy). All members of the CPP must have a professional qualification
in herbal medicine and regularly participate in a professional training scheme,
Continuing Professional Development (CPD), which ensures that they are up to
date with the latest research in both medicine and herbal medicine.
For further information
on the CPP, please visit phytotherapists.org.
Chris is also a Director of the European Herbal and
Traditional Medicines Professional Association (EHTPA) (ehtpa.eu), which is dedicated to the development of herbal/traditional medicine,
preserving and enhancing the legal basis of practice across EU Members States
and promoting best practice throughout different herbal medicine traditions.
List of publications
1. “1-Benzyoxy-3-(p-tolylsulfonyl)propene as an acrolein
β-anion equivalent. Synthesis of 4-substituted
2-butenolides”,
Craig, D, Etheridge, CJ, Smith, AM TETRAHEDRON
LETTERS 1992, 33 (48),
7445-7446.
2. “1-Benzyloxy-3-(p-tolylsulfonyl)alkenes as enal β-anion
equivalents. Synthesis of 2,3-disubstituted furans”, Craig, D,
Etheridge, CJ TETRAHEDRON LETTERS 1993, 34 (46), 7487-7488.
3. “(Alkoxyallyl)sulfones as enal β-anion equivalents. Synthesis of 5-substituted
2(5H)-furanones”, Craig, D, Etheridge, CJ,
Smith, AM TETRAHEDRON 1996, 52 (48), 15267-15288.
4. “(Alkoxyallyl)sulfones as enal and enone β-anion
equivalents. Synthesis of mono-, di-
and trisubstituted furans”, Craig, D, Etheridge, CJ TETRAHEDRON
1996, 52 (48), 15289-15310.
5. “Microspheres, microcapsules and liposomes”, Cooper, RG, Etheridge,
CJ, Miller, AD, Stewart, L (Ed. Arshady_R), John
Wiley & Sons, 1997.
6. “Intrathecal administration of cationic liposome vectors for gene delivery to the
central nervous system”, McQuillin, A, Murray, K,
Stewart, L, Etheridge, CJ, Cooper, RG, Miller, AD, Gurling,
HMD AMERICAN JOURNAL OF MEDICAL GENETICS
1997, 74 (6), 600.
7. “Optimisation of liposome mediated transfection
of a neuronal cell line”, McQuillin, A, Murray,
KD, Etheridge, CJ, Stewart, L, Cooper, RG, Brett, PM, Miller, AD, Gurling, HMD NEUROREPORT
1997, 8 (6), 1481-1484.
8. “Polyamine analogues of 3 beta-[N-(N',N'-dimethylaminoethane)carbomoyl]-cholesterol (DC-Chol)
as agents for gene delivery”, Cooper, RG, Etheridge, CJ, Stewart, L,
Marshall, J, Rudginsky, S, Cheng, SH, Miller, AD, CHEMISTRY-A EUROPEAN JOURNAL 1998, 4 (1), 137-151.
9. “Endothelial cell transfection with cationic liposomes and herpes simplex thymidine
kinase mediated killing”, Fife, K, Bower, M, Cooper, RG, Stewart, L,
Etheridge, CJ, Coombes, RC, Buluwela,
L, Miller, AD, GENE THERAPY 1998, 5 (5). 614-620.
10. “Enhanced in vitro and in vivo gene delivery using cationic agent
complexed retrovirus vectors”, Themis, M, Forbes,
SJ, Chan, L, Cooper, RG, Etheridge, CJ, Miller, AD, Hodgson, HJF, Coutelle, C, GENE
THERAPY 1998, 5 (9), 1180-1186.
11. “Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon”,
Murray, KD, McQuillin, A, Stewart, L, Etheridge, CJ,
Cooper, RG, Miller, AD, Gurling, HMD GENE THERAPY 1999, 6 (2), 190-197.
12. “Comparison of rosmarinic
acid content in commercial tinctures produced from fresh and dried lemon balm
(Melissa officinalis)”, Sanchez-Medina, A, Etheridge,
CJ, Hawkes, GE, Hylands, PJ,
Pendry, BA, Hughes, MJ, Corcoran, O, Journal
of PharmACY and Pharmaceutical Science 2007, 10 (4), 455-463.
13. “Natural herbal relief for menopausal symptoms”, Bailey C, Etheridge CJ, ADVANCING
NUTRITION 2012, January issue.